BBVA USA Bancshares’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,826
Closed -$248K 520
2018
Q3
$248K Sell
4,826
-990
-17% -$49.5K 0.01% 488
2018
Q2
$293K Sell
5,816
-7,855
-57% -$398K 0.02% 455
2018
Q1
$698K Sell
13,671
-11,924
-47% -$636K 0.05% 314
2017
Q4
$1.34M Sell
25,595
-9,365
-27% -$465K 0.09% 223
2017
Q3
$1.71M Buy
34,960
+3,872
+12% +$184K 0.11% 181
2017
Q2
$1.5M Buy
31,088
+2,698
+10% +$124K 0.1% 198
2017
Q1
$1.2M Buy
28,390
+3,909
+16% +$162K 0.08% 231
2016
Q4
$1.03M Sell
24,481
-5,397
-18% -$220K 0.07% 243
2016
Q3
$1.31M Sell
29,878
-164
-0.5% -$7.34K 0.09% 202
2016
Q2
$1.31M Buy
30,042
+10,562
+54% +$455K 0.1% 201
2016
Q1
$859K Buy
+19,480
New +$825K 0.06% 276

Other funds holding FMS

BBVA USA Bancshares's FMS Position: Q4 2018 in Review

BBVA USA Bancshares sold out of Fresenius Medical Care (FMS) in Q4 2018, closing a stake of 4,826 shares — an estimated $248K sold.

BBVA USA Bancshares first reported a position in FMS in Q1 2016 and held it in 11 quarters. The position peaked at $1.71M in Q3 2017. 197 funds tracked by Wall St. Rank hold FMS as of Q4 2018.

  • BBVA USA Bancshares reported no remaining Fresenius Medical Care position as of Q4 2018 after selling out during the quarter.
  • BBVA USA Bancshares sold 4,826 Fresenius Medical Care shares in Q4 2018, an estimated $248K.
  • BBVA USA Bancshares first reported a position in Fresenius Medical Care in Q1 2016 and held it in 11 quarters.
  • BBVA USA Bancshares's Fresenius Medical Care position peaked at $1.71M in Q3 2017.
  • 197 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2018.

Based on BBVA USA Bancshares's 13F filing for Q4 2018, filed 8 Feb 2019.